BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 35216595)

  • 1. Prognostic impact of functional mitral regurgitation prior to left ventricular assist device implantation.
    Pausch J; Bhadra O; Mersmann J; Conradi L; Sill B; Barten MJ; Reichenspurner H; Bernhardt AM
    J Cardiothorac Surg; 2022 Feb; 17(1):24. PubMed ID: 35216595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Consequences of functional mitral regurgitation and atrial fibrillation in patients with left ventricular assist devices.
    Hayashi H; Naka Y; Sanchez J; Takayama H; Kurlansky P; Ning Y; Topkara VK; Yuzefpolskaya M; Colombo PC; Sayer GT; Uriel N; Takeda K
    J Heart Lung Transplant; 2020 Dec; 39(12):1398-1407. PubMed ID: 32994093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of mitral regurgitation in patients undergoing left ventricular assist device deployment: A systematic review and meta-analysis.
    Arjomandi Rad A; Zubarevich A; Shah V; Yilmaz O; Vardanyan R; Naruka V; Moorjani N; Ruhparwar A; Punjabi PP; Weymann A
    Artif Organs; 2023 Aug; 47(8):1250-1261. PubMed ID: 37086154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of Residual Mitral Regurgitation After Continuous Flow Left Ventricular Assist Device Implantation.
    Kassis H; Cherukuri K; Agarwal R; Kanwar M; Elapavaluru S; Sokos GG; Moraca RJ; Bailey SH; Murali S; Benza RL; Raina A
    JACC Heart Fail; 2017 Feb; 5(2):81-88. PubMed ID: 28017353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of severe mitral regurgitation on postoperative outcome after durable left-ventricular assist device implantation.
    Zubarevich A; Szczechowicz M; Arjomandi Rad A; Osswald A; Papathanasiou M; Luedike P; Koch A; Pizanis N; Kamler M; Schmack B; Ruhparwar A; Weymann A
    Artif Organs; 2022 May; 46(5):953-963. PubMed ID: 34931335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Right ventricular function and residual mitral regurgitation after left ventricular assist device implantation determines the incidence of right heart failure.
    Tang PC; Haft JW; Romano MA; Bitar A; Hasan R; Palardy M; Wu X; Aaronson KD; Pagani FD
    J Thorac Cardiovasc Surg; 2020 Mar; 159(3):897-905.e4. PubMed ID: 31101350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Residual mitral regurgitation in patients with left ventricular assist device support - An INTERMACS analysis.
    Jain R; Truby LK; Topkara VK
    J Heart Lung Transplant; 2022 Nov; 41(11):1638-1645. PubMed ID: 35379546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of concomitant mitral valve repair for severe mitral regurgitation at the time of continuous-flow left ventricular assist device insertion.
    Sandoval E; Singh SK; Carillo JA; Baldwin ACW; Ono M; Anand J; Frazier OH; Mallidi HR
    Interact Cardiovasc Thorac Surg; 2017 Oct; 25(4):620-623. PubMed ID: 28962504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uncorrected pre-operative mitral valve regurgitation is not associated with adverse outcomes after continuous-flow left ventricular assist device implantation.
    Stulak JM; Tchantchaleishvili V; Haglund NA; Davis ME; Schirger JA; Cowger JA; Shah P; Aaronson KD; Pagani FD; Maltais S
    J Heart Lung Transplant; 2015 May; 34(5):718-23. PubMed ID: 25697807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Residual Mitral Regurgitation on Right Ventricular Systolic Function After Left Ventricular Assist Device Implantation.
    Ertugay S; Kemal HS; Kahraman U; Engin C; Nalbantgil S; Yagdi T; Ozbaran M
    Artif Organs; 2017 Jul; 41(7):622-627. PubMed ID: 27873344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitral valve repair for severe mitral valve regurgitation during left ventricular assist device implantation.
    Pawale A; Itagaki S; Parikh A; Pinney SP; Adams DH; Anyanwu AC
    J Thorac Cardiovasc Surg; 2019 May; 157(5):1841-1848.e1. PubMed ID: 31288361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of concomitant mitral valve procedures for severe mitral regurgitation during left ventricular assist device implantation.
    Kawabori M; Kurihara C; Conyer RT; Critsinelis AC; Sugiura T; Rosengart T; Morgan JA
    J Artif Organs; 2019 Jun; 22(2):91-97. PubMed ID: 30361785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Concomitant Mitral Valve Surgery With LVAD Placement: Systematic Review and Meta-Analysis.
    Choi JH; Luc JGY; Moncho Escrivá E; Phan K; Rizvi SSA; Patel S; Entwistle JW; Morris RJ; Massey HT; Tchantchaleishvili V
    Artif Organs; 2018 Dec; 42(12):1139-1147. PubMed ID: 30101551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgically Corrected Mitral Regurgitation During Left Ventricular Assist Device Implantation Is Associated With Low Recurrence Rate and Improved Midterm Survival.
    Tanaka A; Onsager D; Song T; Cozadd D; Kim G; Sarswat N; Adatya S; Sayer G; Uriel N; Jeevanandam V; Ota T
    Ann Thorac Surg; 2017 Mar; 103(3):725-733. PubMed ID: 27659599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors and clinical implications of residual mitral regurgitation following left ventricular assist device therapy.
    Sharma H; Liu B; Yuan M; Shakeel I; Morley-Smith A; Hatch A; Bradley J; Chue C; Myerson SG; Steeds RP; Lim S
    Open Heart; 2023 Jun; 10(1):. PubMed ID: 37316326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of left ventricular assist device implantation on mitral regurgitation: An analysis from the MOMENTUM 3 trial.
    Kanwar MK; Rajagopal K; Itoh A; Silvestry SC; Uriel N; Cleveland JC; Salerno CT; Horstmanshof D; Goldstein DJ; Naka Y; Bailey S; Gregoric ID; Chuang J; Sood P; Mehra MR
    J Heart Lung Transplant; 2020 Jun; 39(6):529-537. PubMed ID: 32279919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Baseline Mitral Regurgitation on Postoperative Outcomes After Left Ventricular Assist Device Implantation as Destination Therapy.
    Okoh A; Yanagida R; Schultheis M; Chaudari S; Fugar S; Nnaoma C; Chan O; Zucker MJ; Karanam R; Russo MJ; Camacho M
    Transplant Proc; 2019 Apr; 51(3):859-864. PubMed ID: 30979476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of mitral regurgitation reversibility in patients with HeartMate 3 LVAD implantation.
    Schreiber C; Dieterlen MT; Garbade J; Borger MA; Sieg F; Spampinato R; Dobrovie M; Meyer AL
    Artif Organs; 2022 Jan; 46(1):106-116. PubMed ID: 34398476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-operative echocardiographic features associated with persistent mitral regurgitation after left ventricular assist device implantation.
    Kitada S; Kato TS; Thomas SS; Conwell SD; Russo C; Di Tullio MR; Farr M; Schulze PC; Uriel N; Jorde UP; Takayama H; Naka Y; Homma S; Mancini DM
    J Heart Lung Transplant; 2013 Sep; 32(9):897-904. PubMed ID: 23850122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of residual mitral regurgitation after left ventricular assist device implantation.
    Kimura Y; Okumura T; Kazama S; Shibata N; Oishi H; Arao Y; Kuwayama T; Kato H; Yamaguchi S; Hiraiwa H; Kondo T; Morimoto R; Mutsuga M; Fujimoto K; Usui A; Murohara T
    Int J Artif Organs; 2021 Feb; 44(2):101-109. PubMed ID: 32677853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.